Application | Comment | Organism |
---|---|---|
medicine | lon is a target in the development of antibiotics | Salmonella enterica subsp. enterica serovar Typhimurium |
Cloned (Comment) | Organism |
---|---|
recombinant wild-type and mutant lon overexpressed in Escherichia coli BL21 (DE3), using plasmids pHF020 and pHF031, respectively | Salmonella enterica subsp. enterica serovar Typhimurium |
Protein Variants | Comment | Organism |
---|---|---|
S680A | displays both intrinsic and peptide-stimulated ATP hydrolysis activity comparable to that of the wild-type enzyme but is unable to catalyze peptide bond hydrolysis. Active site serine is required for interaction of inhibitor with lon | Salmonella enterica subsp. enterica serovar Typhimurium |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
dansyl-YRGIT-Abu | not time-dependent inhibitor of peptide hydrolysis activity of lon | Salmonella enterica subsp. enterica serovar Typhimurium | |
dansyl-YRGIT-Abu-B(OH)2 | potent time-dependent inhibitor of peptide hydrolysis activity of lon, inhibition requires the binding but not hydrolysis of ATP, is an alternative peptidyl boronate inhibitor | Salmonella enterica subsp. enterica serovar Typhimurium | |
MG262 | potent time-dependent inhibitor of peptide hydrolysis activity of lon, inhibition requires the binding but not hydrolysis of ATP | Salmonella enterica subsp. enterica serovar Typhimurium |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Salmonella enterica subsp. enterica serovar Typhimurium | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Salmonella enterica subsp. enterica serovar Typhimurium |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
YRGIT-Abu-SGRQK(Bz) + H2O | - |
Salmonella enterica subsp. enterica serovar Typhimurium | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
lon protease | - |
Salmonella enterica subsp. enterica serovar Typhimurium |